Cargando…
Outcomes Following Macrolide Use in Kidney Transplant Recipients
BACKGROUND: Calcineurin inhibitors (CNI; cyclosporine, tacrolimus) are critical for kidney transplant immunosuppression, but have multiple potential drug interactions, such as with macrolide antibiotics. Macrolide antibiotics (clarithromycin, erythromycin, and azithromycin) are often used to treat a...
Autores principales: | Jeong, Rachel, Quinn, Robert R., Lentine, Krista L., Lloyd, Anita, Ravani, Pietro, Hemmelgarn, Brenda, Braam, Branko, Garg, Amit X., Wen, Kevin, Wong-Chan, Anita, Gourishankar, Sita, Lam, Ngan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385328/ https://www.ncbi.nlm.nih.gov/pubmed/30815270 http://dx.doi.org/10.1177/2054358119830706 |
Ejemplares similares
-
Follow-up Care of Living Kidney Donors in Alberta, Canada
por: Lam, Ngan N., et al.
Publicado: (2018) -
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020) -
Long-Term Outcomes for Living Kidney Donors With Early
Guideline-Concordant Follow-up Care: A Retrospective Cohort
Study
por: Dhalla, Anisha, et al.
Publicado: (2023) -
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation
por: Lam, Ngan N., et al.
Publicado: (2018) -
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)